Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix
Open Access
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 25 (11) , 1858-1867
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care & Research, 2012
- The Role of Growth Factors in Cartilage RepairClinical Orthopaedics and Related Research, 2011
- RETRACTED ARTICLE: Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytesArthritis Research & Therapy, 2011
- Effects of Low Concentration BMP-7 on Human Osteoarthritic Chondrocytes: Comparison of Different ApplicationsJournal of Biomaterials Applications, 2010
- Effects of intermittent hydrostatic pressure and BMP‐2 on osteoarthritic human chondrocyte metabolism in vitroJournal of Orthopaedic Research, 2010
- Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophyAnnals of the Rheumatic Diseases, 2010
- The Transcriptional Activity of Sox9 in Chondrocytes Is Regulated by RhoA Signaling and Actin PolymerizationMolecular and Cellular Biology, 2009
- Joint homeostasis, restoration, and remodeling in osteoarthritisBest Practice & Research Clinical Rheumatology, 2008
- RhoA/ROCK Signaling Regulates Chondrogenesis in a Context-dependent MannerJournal of Biological Chemistry, 2006
- Microfilament modification by dihydrocytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape.Journal of Cell Biology, 1988